Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1
Offer reference number: CM/PHG/22/5666
Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months.
CM/PHG/22/5666/00 - Transition Products:
CESW 01/08/2023 - 31/01/2024 (6 months)
NWLN 01/08/2023 - 31/01/2025 (18 months)
LSNE 01/08/2023 - 31/05/2024 (10 months)
CM/PHG/22/5666/01 - Orals Oral (plus non-parenteral) Products:
All regions: 01/08/2023 to 31/05/2024 (10 months)
No supplier information available.